European Case Law Identifier: | ECLI:EP:BA:1999:T099495.19990218 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 18 February 1999 | ||||||||
Case number: | T 0994/95 | ||||||||
Application number: | 82903424.8 | ||||||||
IPC class: | C07H 21/02 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Oligonucleotide therapeutic agent and methods of making same | ||||||||
Applicant name: | Molecular Biosystems, Inc. | ||||||||
Opponent name: | Chugai Seiyaku Kabushiki Kaisha Applied Biosystems, Inc. Hoechst Aktiengesellschaft Zentrale Patentabteilung Gen- Probe Inc. Novartis AG Patent and Trademark Dept. Genta Inc. |
||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Sufficiency of disclosure (no) | ||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t950994eu1.html
Date retrieved: 17 May 2021